A Measure of the Proportion of Treatment Effect Explained by a Surrogate Marker
From MaRDI portal
Publication:3079026
DOI10.1111/j.0006-341X.2002.00803.xzbMath1210.62215WikidataQ78698491 ScholiaQ78698491MaRDI QIDQ3079026
Publication date: 1 March 2011
Published in: Biometrics (Search for Journal in Brave)
Applications of statistics to biology and medical sciences; meta analysis (62P10) Medical applications (general) (92C50)
Related Items
A Shrinkage Approach for Estimating a Treatment Effect Using Intermediate Biomarker Data in Clinical Trials, Meta-analysis for Surrogacy: Accelerated Failure Time Models and Semicompeting Risks Modeling, Improving efficiency in clinical trials using auxiliary information: Application of a multi‐state cure model, Causal measures of the treatment effect captured by candidate surrogate endpoints, Evaluating multiple surrogate markers with censored data, Robust methods to correct for measurement error when evaluating a surrogate marker, Quantifying direct and indirect effect for longitudinal mediator and survival outcome using joint modeling approach, Proportion of treatment effect mediated by surrogate endpoints, Robust Approach to Combining Multiple Markers to Improve Surrogacy, Testing for Heterogeneity in the Utility of a Surrogate Marker, Evaluation of longitudinal surrogate markers, Bounds on Direct Effects in the Presence of Confounded Intermediate Variables, Bayesian inference for causal mediation effects using principal stratification with dichotomous mediators and outcomes, A Bayesian Approach to Surrogacy Assessment Using Principal Stratification in Clinical Trials, The Identification of Direct and Indirect Effects in Studies with an Unmeasured Intermediate Variable, Assessing the value of a censored surrogate outcome, Semiparametric Inference for Surrogate Endpoints with Bivariate Censored Data, Exploring the Relationship Between Surrogates and Clinical Outcomes: Analysis of Individual Patient Data vs. Meta-regression on Group-Level Summary Statistics, Equivalence between direct and indirect effects with different sets of intermediate variables and covariates, On Assessing Surrogacy in a Single Trial Setting Using a Semicompeting Risks Paradigm, Linear increment in efficiency with the inclusion of surrogate endpoint
Cites Work
- Unnamed Item
- Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy
- The validation of surrogate endpoints in meta-analyses of randomized experiments
- Criteria for the Validation of Surrogate Endpoints in Randomized Experiments
- Modeling the Relationship of Survival to Longitudinal Data Measured with Error. Applications to Survival and CD4 Counts in Patients with AIDS
- Confidence intervals and statistical power of the ``Validation ratio for surrogate or intermediate endpoints
